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ABSTRACT
Background: Inflammation is a complex physiopathologic response to different stimuli. Recently, 
some pharmacological strategies have been proposed that could be used for resolution of inflammation 
by enhancing apoptosis of inflammatory cells. Objectives: To study in vitro apoptotic activity of isoes-
pintanol [ISO] and of two semi-synthetic derivatives, bromide isoespintanol [BrI] and demethylated 
isoespintanol [DMI], in human polymorphonuclear (PMN) cells. Methods: PMN were exposed to 
the different concentrations of ISO, BrI and DMI for 30 min in phosphate-buffered saline pH 7.4 con-
taining 1 mg/mL glucose, 0.4 mM Mg2+, and 1.20 mM Ca2+. Viability was assessed by dimethylthiazol 
diphenyl tetrazolium bromide (MTT). To distinguish between the two modes of cell death, apoptosis 
and necrosis, we examined differences in morphological and biochemical changes of cells stained with 
annexin V- FITC (An) and/or propidium iodide (PI) using two different assays based on flow cytometry 
Results: The MTT assay revealed the ability of cells to reduce MTT salt to formazan. In the presence of 
BrI and DMI a significant concentration-dependent decrease of cell viability was observed. The annexin 
V- FITC binding assay showed a high proportion of apoptotic cells for those treated with BrI (An+/ PI-: 
62.3 ± 8.2% vs. 2.1 ± 0.5% of control, P<0.05). The population of PMN treated with DMI produced 
the highest percentage (An+/IP+: 43.4 ± 5.2 % vs. 0.4 ± 0.3 % of control, P<0.05) of necrotic cells. 
Apoptotic nuclei were analyzed by PI staining. The cell population in the sub G0/G1 region represents 
cells with hypodiploidal DNA, an indicator of apoptosis. When cells were incubated with 50 and 100 
μM of BrI, the cell population in the sub G0/G1 region increased, suggesting a dose-dependent increase 
in the population of apoptotic cells. The presence of the pan-inhibitor of caspases (Z-VAD-fmk) showed 
a significant reduction in cell population in the sub G0/G1 region, indicating less degradation of DNA. 
Conclusions: Bromide isoespintanol [BrI] induces an apoptotic process in PMN, mediated –at least 
in part– by activation of caspases, although this compound may probably act through other caspase-
independent mechanisms as well.
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RESUMEN
Antecedentes: La inflamación es una respuesta fisiopatológica compleja generada por diferentes estí-
mulos. Recientemente, se han propuesto nuevas estrategias farmacológicas que podrían ser utilizadas para 
conducir a la resolución de la inflamación mediante el aumento de la apoptosis de células inflamatorias. 
Objetivo: Estudiar la actividad apoptótica in vitro del isopentanol [ISO] y dos derivados semisintéticos 
–bromuro de isoespintanol [BrI] e isoespintanol desmetilado [DMI] – en células polimorfonucleares 
humanas (PMN). Métodos: Las PMN fueron expuestas a diferentes concentraciones de los compuestos 
durante 30 min en una disolución salina tamponada con fosfato (pH 7,4). La viabilidad celular se evaluó 
utilizando el ensayo de 3-[4,5-dimetil-tiazol-2-il]-2,5-difenil tetrazolio (MTT). Para distinguir entre 
los dos modos de muerte celular, la apoptosis y la necrosis, se examinaron las diferencias en los cambios 
morfológicos y bioquímicos de las células teñidas con anexina V (An) y/o yoduro de propidio (PI) usando 
dos técnicas de citometría de flujo. Resultados: Mediante el ensayo con MTT, se demostró que los com-
puestos BrI y DMI disminuyeron significativamente y de manera concentración-dependiente la viabilidad 
celular. El ensayo de unión con la anexina V-FITC mostró una alta proporción de células apoptóticas en 
las células tratadas con BrI (An+/PI-: 62,3 ± 8,2% versus 2,1 ± 0,5% del control, P <0,05). La población 
de células tratadas con DMI mostraron el porcentaje más alto de células necróticas (A+/PI+: 43,4 ± 5,2% 
versus 0,4 ± 0,3% del control, P <0,05). El análisis de núcleos apoptóticos se llevó a cabo a través de 
tinción con PI. La población de células en la región sub G0/G1 representa células con ADN hipodiploidal, 
que es un indicador de apoptosis. Cuando las células se incubaron con BrI, la población de células en 
la región sub G0/G1 aumentó, confirmando su mecanismo citotóxico. En presencia de un inhibidor de 
caspasas (Z-VAD-FMK), se observó una reducción significativa en la población celular en la región sub 
G0/G1, indicando una menor degradación del ADN. Conclusiones: El bromuro de isoespintanol [BrI], 
induce un proceso apoptótico en PMN que está mediado –al menos en parte– por la activación de las 
caspasas, aunque este compuesto probablemente podría actuar también a través de otros mecanismos 
independientes de las caspasas.
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INTRODUCTION
Mature human neutrophils have the shortest life 
span of all leukocytes; their spontaneous apoptosis 
is therefore fundamental for maintaining a nor-
mal level of circulating neutrophils and ensuring 
rapid resolution of inflammatory responses (1). Not 
surprisingly, a reduction in neutrophil apoptosis 
has already been linked to several inflammatory 
conditions including rheumatoid arthritis and acute 
respiratory distress syndrome (2, 3). 
The occurrence of isoespintanol (2-isopro-
pyl-3,6-dimethoxy-5-methylphenol) was reported 
in the chloroform extract of aerial parts of Eupato-
rium saltense (4) and has also been synthesized as part 
of the structure elucidation of the natural product 
espintanol (5). Recently, we demonstrated that 
isoespintanol, isolated from the leaves of Oxandra 
cf. xylopioides, reduces paw edema induced by car-
rageenan. Moreover, it reduces IL-1b production 
and decreases IL-1b mRNA synthesis in murine 
macrophages RAW264.7, both mechanisms pos-
sibly responsible for its anti-inflammatory action 
(6). We also studied and demonstrated its antioxi-
dant activity in both theoretical and experimental 
protocols (7, 8). 
In this work, we study in vitro apoptotic activity 
of isoespintanol [ISO] and two semisynthetic de-
rivatives, bromide isoespintanol [BrI] and demeth-
ylated isoespintanol [DMI] Figure 1, on human 
polymorphonuclear (PMN) cells. 
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MATERIALS AND METHODS
Test compounds and chemicals
Isoespintanol [ISO, purity >99%, 1H-NMR] 
was previously isolated from leaves of Oxandra cf. 
xylopioides. BrI and DMI (purity of both >99%, 
1H-NMR) were obtained from isoespintanol as 
previously reported by Galeano et al. (9). All other 
chemicals were the highest analytic grade available 
and were purchased from Sigma-Aldrich (USA) or 
from Merck (Germany).
Cell isolation and culturing
Neutrophils were isolated from fresh anti-
coagulated peripheral blood obtained from healthy 
volunteers, then purified using a standard protocol. 
Briefly, erythrocytes were sedimented by adding 
an equal volume of dextran/saline solution (3% 
dextran T-500 in 0.9% NaCl) at room temperature 
for 30 min. The leukocyte-rich upper layer of the 
suspension was then collected and centrifuged on 
a density gradient with Histopaque®-1077 (Sigma-
Aldrich) according to manufacturer’s instructions.
Residual erythrocytes were removed by hypo-
tonic lysis (cold water). Neutrophils were washed 
twice in phosphate-buffered saline (PBS) pH 7.4, 
then resuspended in the same buffer containing 1 
mg/mL glucose, 0.4 mM Mg2+, and 1.20 mM Ca2+. 
Cell viability was determined by the trypan blue 
dye exclusion method.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assay 
The MTT assay (10) was used to determine the 
cytotoxicity of the compounds. Briefly, human 
PMN cells (2.5 × 106) were incubated at 37 °C for 3 
h with PBS (pH 7.4) containing the compounds (1 – 
100 μM). Controls were treated with the vehicle and 
correspond to 100% viability. Formazan deposits 
produced by the cells in each tube were dissolved 
in a solution of 10% sodium dodecyl sulfate (SDS) 
in 0.01 M HCl and tubes were incubated overnight. 
The soluble product was quantified, measured at 
570 nm (with background subtraction at 630 nm) 
in a Beckman DU 640. 
Analysis of apoptotic (hypodiploid) nuclei 
Apoptotic nuclei were analyzed by propidium 
iodide staining, based on the protocol described 
by Nicoletti et al. (11) with slight modifications. 
Brief ly, cells were incubated under the same 
conditions previously described, then centrifuged 
(500×g). The resulting pellet was suspended in ice-
cold ethanol (70%) and stored at –20 ºC for at least 
30 min. Cells were then washed twice in PBS at 4 
ºC and resuspended in 500 mL of DNA staining 
solution (20 mg/mL PI plus 0.2 mg/mL RNAse A 
in PBS). Resuspended cells were incubated in the 
dark at room temperature for 30 min, after which 
fluorescence of individual nuclei was measured 
with a Becton Dickinson FACSScan flow cyto-
meter (USA). A minimum of 20,000 events were 
counted per sample. The percentage of apoptotic 
cell nuclei (hypodiploid DNA peak) was then cal-
culated. Benzyloxycarbonyl-Val-Ala-Asp (OMe) 
fluoromethylketone (Z-VAD-fmk), a pan-inhibitor 
of caspases, was added to the cell suspension just 
before application of each compound.
Annexin V-fluorescein isothiocyanate (FITC) 
in apoptotic cells
Phosphatidylserine exposure was measured by 
annexin V-FITC binding (12). After appropriate 
incubations with the compounds (100 mM), cells 
Figure 1. Chemical structures of isoespintanol (2-isopropyl-3,6-dimethoxy-5-methylphenol, ISO), isoespintanol 
4-bromide (BrI) and 3,6-demethylated isoespintanol (DMI).
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(2.5 × 106) were washed twice with cold PBS and 
resuspended in a binding buffer solution (10 mM 
Hepes/NaOH pH 7.4, 140 mM NaCl, 2.5 mM 
CaCl2) at a concentration of 1 × 10
6 cells/mL. Then, 
1 × 105 cells were transferred to a 5 mL culture tube 
to which 5 mL of Annexin V-FITC and 10 mL 
of propidium iodide solution (50 mg/mL in PBS) 
were added. Tubes were then incubated for 15 min 
at room temperature in the dark. After incubation, 
400 mL of binding buffer were added to each tube 
and flow cytometry analyses were run. 
Statistical analysis
Results are expressed as means ± SD for the 
indicated number of observations or illustrated by 
an observation representative of results from seve-
ral different experiments. Statistical analysis used 
ANOVA followed by Dunnett’s t-test for multiple 
comparisons using the Prism analysis program 
(GraphPad). Differences were considered signifi-
cant when P<0.05.
RESULTS 
Our research included an assessment of the 
cytotoxicity of the extracts on human PMN cells. 
The MTT assay revealed that the ability of cells to 
reduce the MTT salt to formazan decreased sig-
nificantly in the presence of BrI and DMI (Figure 
2). The results were expressed as a percentage of 
the control (cells treated with 0.5% DMSO). No 
cytotoxic activity was detected in selected concen-
trations of ISO. 
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Figure 2. Effects of isoespintanol [ISO] and related 
compounds [BrI and DMI] in four concentrations 
(1, 10, 50 and 100 mM) on cell viability of PMN cells. 
Values represent percentages of live cells compared to 
the control group treated with vehicle only (culture 
medium with 0.5% dimethyl sulfoxide). Data represent 
the mean and standard deviation of f ive different 
experiments. The symbol * indicates the significant 
difference (P<0.05). 
The nature of the cytotoxicity was evaluated 
with different flow cytometry methods, including 
the exposure of membrane phosphatidylserine 
through Annexin V-FITC binding and the develo-
pment of hypodiploid nuclei by propidium iodide. 
While only a small proportion of PMN untrea-
ted or treated with ISO underwent apoptosis [An-
nexin V-FITC positive, propidium iodide negative 
(An+/IP-)], the proportion was significantly greater 
for the cells treated with BrI (An+/ PI-: 62.3 ± 8.2% 
vs. 2.1 ± 0.5% of control, P<0.05). The population 
of PMN cells treated with DMI produced the hig-
hest percentage (A+/IP+: 43.4 ± 5.2 % vs. 0.4 ± 0.3 
% of control, P<0.05) with a typical distribution 
indicative of the necrotic process (Figure 3).
Figure 3. Promotion of apoptosis in neutrophils 
by isoespintanol and related compounds. Represen-
tative dot plots of annexin V-FITC (An) /propidium 
iodide (PI) staining. The lower left quadrant shows 
the vital (double negative) population. The lower 
right quadrant shows the apoptotic (An+/PI–) popula-
tion. Finally, cells in the top right quadrant (An+/PI+) 
are in later stages of apoptosis and necrosis. Graph 
shows the experiment of the compounds at 100 μM. 
Data are representative of three experiments. 
The relative distribution of DNA in the cells 
incubated with 50 and 100 μM of BrI is shown in 
Figure 4A and 4B. The line in the sub G0/G1 region 
of the histogram indicates the range of cells with 
hypodiploidal DNA, an indicator of apoptosis. The 
results showed that BrI-induced concentration-
dependent changes in the percentage population 
of cells with hypodiploidal DNA.
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In order to investigate involvement of caspase 
activation in BrI-induced cell death, the effect of 
the pan-inhibitor of caspases (Z-VAD-fmk) was 
examined (Figura 4A and 4B). The increase in the 
population of cells with hypodiploidal DNA indu-
ced by BrI was suppressed by 30 μM Z-VAD-fmk, 
showed a significant reduction in the cell popula-
tion in the sub G0/G1 region (Figura 4B).
DISCUSSION
Inflammation is a complex physiopathologic 
response to different stimuli. It can be treated and 
resolved by acting on different mediators, enzy-
mes, and pathways involved in the process. This 
may include influencing arachidonate metabolism 
by inhibiting either certain transcription factors 
or production and/or scavenging of free radicals 
produced during the process, and by acting on cells 
involved in the process. New cellular and molecular 
circuits involved in resolution of inflammation are 
being found at a rapid pace. In some experimental 
models, a causal relationship has been detected 
between neutrophil apoptosis and the outcome of 
acute tissue injury (13). Recently, several publica-
tions have proposed pharmacological strategies that 
could be used for resolution of inflammation by 
enhancing apoptosis of inflammatory cells (1, 14). 
Consequently, our research included assessment 
of the cytotoxicity of monoterpene isoespintanol 
[ISO] and two related compounds, BrI and DMI, 
on human PMN cells. 
In the presence of BrI and DMI a significant and 
concentration-dependent decrease of cell viability 
was observed. No cytotoxic activity was detected 
in the assay of compound ISO (Figure 2). 
To distinguish between the two modes of cell 
death, apoptosis and necrosis, we examined diffe-
rences in morphological and biochemical changes 
of dying cells by two different assays based on flow 
cytometry techniques. 
As shown by the annexin V- FITC binding assay 
(Figure 3), the proportion of apoptotic cells was 
much greater for those treated with BrI (An+/ PI-: 
62.3 ± 8.2% vs. 2.1 ± 0.5% of control, P<0.05). 
The population of PMN cells treated with DMI 
produced a typical distribution indicative of the 
Figure 4 (A and B). Effects of Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD-fmk) on BrI-
induced changes in the percentage population of cells with hypodiploidal DNA. A) The histogram of propidium 
iodide fluorescence monitored from 20,000 cells. The line in the sub G0/G1 region of the histogram indicates 
the range of cells with hypodiploidal DNA; B) BrI-induced concentration-dependent changes in the percentage 
population of cells with hypodiploidal DNA. The column and bar indicate the mean and standard deviation of 
4–6 experiments. The symbol * indicates the significant difference (P<0.05) between the control group and the 
BrI-treated group. The symbol # indicates a significant difference (P<0.05) between groups with and without 30 
μM Z-VAD-fmk treatment.
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necrotic process (Figure 3), for this reason, it was 
not selected for the following studies.
The relative distribution of DNA in the cells in-
cubated with BrI is shown in Figure 4A and 4B. The 
cell population in the sub G0/G1 region as shown in 
Figure 4A represents cells with hypodiploidal DNA, 
an indicator of apoptosis. When cells were incubated 
with 50 and 100 μM of BrI, the cell population in 
the sub G0/G1 region increased, suggesting that BrI 
induced a dose-dependent increase in the popula-
tion of apoptotic cells Figure 4A. 
Apoptosis of granulocytes is a sensitive, respon-
sive and highly regulated process. Various signaling 
pathways confer these features. Each pathway is 
responsive to specific endogenous stimuli and 
mediates pro- or anti-apoptotic effects; some are 
dependent on the intervention of caspases and other 
independents (1, 13-17).
Caspases are a family of cysteine proteases that 
play essential roles in apoptosis, necrosis, and in-
flammation (18). These proteases are essential in 
cells for apoptosis, or programmed cell death, and 
their role in the mechanism of active compounds 
can be investigated using Z-VAD-fmk, a pan-
inhibitor of caspases (19). For studying the possible 
effects of our compounds on this way of programed 
cell death, we applied the inhibitor to cell culture 
in order to know the possible inhibition of capases 
can be related with the mechanism of isoespintanol 
and its derivatives. The presence of Z-VAD-fmk 
showed a significant reduction in the cell popula-
tion in the sub G0/G1 region, indicating less DNA 
degradation Figure 4B, whereas the presence of the 
inhibitor suppressed the increase in the cell popu-
lation with hypodiploidal DNA induced by BrI. 
In this paper, we intend to contribute to evi-
dence of the ability of some compounds to induce 
apoptosis in PMN. We conclude that BrI induce 
an apoptotic process in human PMN cells partially 
mediated by activation of caspases, although this 
compound may also probably act through other 
caspase-independent mechanisms. 
We agree that extrapolation in vivo of results 
obtained in cultured cells with a compound is 
problematic and that is why commentaries on such 
potential extrapolation in the text of the manuscript 
are very cautious. Further studies should focus on 
studying possible mechanisms of action of this com-
pound, which contributes to neutrophil apoptosis, 
as well as its potential anti-inflammatory activity 
in in vivo models.
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